Humacyte, Inc. (HUMA) Reports In-Line Q4 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. AVGO
2. CDNS
3. SPY
4. META
5. JBLU
6. ANT
7. ARTV
8. AAPL
9. SSD
10. BA

Go back to Humacyte, Inc. (HUMA) Reports In-Line Q4 EPS

Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update

March 27, 2026 7:00 AM EDT

- Total revenues from sales and research collaborations were $0.5 million for fourth quarter and $2.0 million for full year - 

- Purchase commitment received for a minimum of $1.475 million for a clinical evaluation and outreach program in the Kingdom of Saudi Arabia -

- Submitted of a Marketing Authorization Application with the Israel Ministry of Health -

- U.S. Department of Defense authorized funding for procurement of bioengineered blood vessels -

- Major milestone upcoming:... More